These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 8227275
1. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity. Gray JJ, Cohen BJ, Desselberger U. J Virol Methods; 1993 Sep; 44(1):11-23. PubMed ID: 8227275 [Abstract] [Full Text] [Related]
2. Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection. Pereira RF, Paula WN, Cubel Rde C, Nascimento JP. Mem Inst Oswaldo Cruz; 2001 May; 96(4):507-13. PubMed ID: 11391423 [Abstract] [Full Text] [Related]
3. Use of recombinant human parvovirus B19 antigens in serological assays. Cubie HA, Leslie EE, Smith S, O'Neill HJ, Hart H, Cohen BJ, Inglis JM. J Clin Pathol; 1993 Sep; 46(9):840-5. PubMed ID: 8227436 [Abstract] [Full Text] [Related]
8. An immunofluorescence assay for the detection of parvovirus B19 IgG and IgM antibodies based on recombinant viral antigen. Brown CS, van Bussel MJ, Wassenaar AL, van Elsacker-Niele AM, Weiland HT, Salimans MM. J Virol Methods; 1990 Jul; 29(1):53-62. PubMed ID: 2170436 [Abstract] [Full Text] [Related]
9. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection. Kerr JR, Coyle PV, DeLeys RJ, Patterson CC. J Med Virol; 1996 Jan; 48(1):68-75. PubMed ID: 8825713 [Abstract] [Full Text] [Related]
11. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection. Pfrepper KI, Enders M, Motz M. J Vet Med B Infect Dis Vet Public Health; 2005 Jan; 52(7-8):362-5. PubMed ID: 16316402 [Abstract] [Full Text] [Related]
15. Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women. Jordan JA. J Clin Microbiol; 2000 Apr 20; 38(4):1472-5. PubMed ID: 10747128 [Abstract] [Full Text] [Related]
17. Parvovirus infection in children with AIDS: high prevalence of B19-specific immunoglobulin M and G antibodies. Nigro G, Luzi G, Fridell E, Ferrara M, Pisano P, Gattinara GC, Mezzaroma I, Söderlund M, Rasnoveanu D, Aiuti F. AIDS; 1992 Jul 20; 6(7):679-84. PubMed ID: 1503687 [Abstract] [Full Text] [Related]
18. Antibody capture haemadherence tests for parvovirus B19-specific IgM and IgG. Hilfenhaus S, Cohen BJ, Bates C, Kajigaya S, Young NS, Zambon M, Mortimer PP. J Virol Methods; 1993 Nov 20; 45(1):27-37. PubMed ID: 8270653 [Abstract] [Full Text] [Related]
19. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. Söderlund M, Brown CS, Cohen BJ, Hedman K. J Infect Dis; 1995 Mar 20; 171(3):710-3. PubMed ID: 7876624 [Abstract] [Full Text] [Related]
20. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis. Azzi A, Manaresi E, Zakrzewska K, DeSantis R, Musiani M, Zerbini M. J Med Virol; 2004 Apr 20; 72(4):679-82. PubMed ID: 14981773 [Abstract] [Full Text] [Related] Page: [Next] [New Search]